[
  {
    "date": "2023-12-30",
    "symbol": "RCUS",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "currentfiscalyearenddate": "--12-31",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38419",
    "entityregistrantname": "Arcus Biosciences, Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-3898435",
    "entityaddressaddressline1": "3928 Point Eden Way",
    "entityaddresscityortown": "Hayward",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94545,
    "cityareacode": 510,
    "localphonenumber": "694-6200",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "tradingsymbol": "RCUS",
    "securityexchangename": "NYSE",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young, LLP",
    "auditorlocation": "San Mateo, California",
    "entitycentralindexkey": 1724521,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "revenuefromcontractwithcustomerexcludingassessedtax": 80000000,
    "researchanddevelopmentexpense": 340000000,
    "generalandadministrativeexpense": 117000000,
    "operatingexpenses": 457000000,
    "operatingincomeloss": -340000000,
    "interestandotherincomeexpensenonoperatingnet": 41000000,
    "effectiveinterestonliabilityforsaleoffutureroyalties": 2000000,
    "nonoperatingincomeexpense": 39000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -301000000,
    "incometaxexpensebenefit": 6000000,
    "netincomeloss": -307000000,
    "incomelossfromcontinuingoperationsperbasicshare": -4.15,
    "incomelossfromcontinuingoperationsperdilutedshare": -4.15,
    "weightedaveragenumberofsharesoutstandingbasic": 74000000,
    "weightedaveragenumberofdilutedsharesoutstanding": 74000000,
    "researchanddevelopmentexpenserecoveries": 110000000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 7000000,
    "comprehensiveincomenetoftax": -300000000,
    "cashandcashequivalentsatcarryingvalue": 127000000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 632000000,
    "contractwithcustomerassetnetcurrent": 20000000,
    "prepaidexpenseandotherassetscurrent": 34000000,
    "assetscurrent": 831000000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 107000000,
    "propertyplantandequipmentnet": 51000000,
    "otherassetsnoncurrent": 6000000,
    "assets": 1095000000,
    "accountspayablecurrent": 17000000,
    "contractwithcustomerliabilitycurrent": 84000000,
    "otherliabilitiescurrent": 76000000,
    "liabilitiescurrent": 184000000,
    "contractwithcustomerliabilitynoncurrent": 291000000,
    "otherliabilitiesnoncurrent": 142000000,
    "commonstockvalue": 1311000000,
    "retainedearningsaccumulateddeficit": -849000000,
    "stockholdersequity": 462000000,
    "liabilitiesandstockholdersequity": 1095000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 75500000,
    "commonstocksharesoutstanding": 75500000,
    "stockissuedduringperiodsharesnewissues": 1200000,
    "stockissuedduringperiodvaluenewissues": 25000000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 73000000,
    "othercomprehensiveincomelossnetoftax": 7000000,
    "profitloss": -307000000,
    "sharebasedcompensation": 73000000,
    "depreciationandamortization": 8000000,
    "operatingleaserightofuseassetamortizationexpense": 8000000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 19000000,
    "otheroperatingactivitiescashflowstatement": 2000000,
    "increasedecreaseincontractwithcustomerasset": -19000000,
    "increasedecreaseinothernoncurrentassets": -4000000,
    "increasedecreaseinaccountspayable": -1000000,
    "increasedecreaseincontractwithcustomerliability": -77000000,
    "increasedecreaseinothernoncurrentliabilities": -3000000,
    "netcashprovidedbyusedinoperatingactivities": -306000000,
    "paymentstoacquiremarketablesecurities": 788000000,
    "proceedsfrommaturityofmarketablesecurities": 982000000,
    "proceedsfromsaleofmarketablesecurities": 24000000,
    "paymentstoacquirepropertyplantandequipment": 24000000,
    "netcashprovidedbyusedininvestingactivities": 194000000,
    "proceedsfromissuanceofcommonstock": 20000000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 8000000,
    "netcashprovidedbyusedinfinancingactivities": 33000000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -79000000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 130000000,
    "incometaxespaid": 5000000,
    "capitalexpendituresincurredbutnotyetpaid": 2000000,
    "othersignificantaccountingpoliciespolicytextblock": "Other Significant Accounting PoliciesOur other significant accounting policies are described in the remaining appropriate notes to the Consolidated Financial Statements.",
    "scheduleoftransactionpriceandallocatedtotransactionpricetoperformanceobligationstabletextblock": "The following table summarizes the transaction price and the allocation of the transaction price to the performance obligations (in millions):",
    "summaryofinformationrelatedtooperatingleasestabletextblock": "The following table summarizes information related to our leases, all of which are classified as operating (in millions):As of December 31,Location in Consolidated Balance Sheets20232022Assets:Other noncurrent assets - right-of-use assets$92 $100 Liabilities:  Other current liabilities - net current operating lease liabilities$11 $3 Other noncurrent liabilities - noncurrent operating lease liabilities$110 $117",
    "scheduleofsupplementalcashflowdisclosuresandnoncashfinancingactivitiesrelatedtooperatingleasestabletextblock": "The following table summarizes our cash and non-cash information related to our operating leases (in millions):Year Ended December 31,202320222021Cash paid for amounts included in measurement of lease liabilities$15 $11 $5 Cash received from tenant improvement allowances$9 $8 $3 Right-of-use assets obtained in exchange for new operating lease liabilities$— $3 $95 Recognition of tenant improvement allowance receivable included in Other current liabilities$4 $6 $11",
    "summaryofchangesofliabilitiesforsaleoffutureroyaltiestabletextblock": "The liability for sale of future royalties is reported in Other noncurrent liabilities in the Consolidated Balance Sheets and changes were as follows (in millions):",
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "investmentsandcash": 866000000,
    "propertyplantandequipmentusefullife": "P3Y",
    "righttopurchaseadditionaloutstandingvotingcommonstockpercentage": 0.35,
    "percentageofpremiumpurchasepriceofcommonstock": 0.2,
    "trailingdaysaverageclosingprice": "P5D",
    "shareprice": 33.54,
    "percentageofoutstandingcommonstockowned": 0.196,
    "optioncontinuationpaymentdueuponsecondanniversaryofagreement": 100000000,
    "upfrontcashpayment": 725000000,
    "numberofresearchprograms": 2,
    "optionpaymentuponcompletionofcertainindenablingactivities": 60000000,
    "optionpaymentuponachievementofcertaindevelopmentmilestones": 150000000,
    "contractwithcustomerliabilityrevenuerecognized": 112000000,
    "relatedpartytransactionreimbursementfromrelatedpartyforsharedcosts": 110000000,
    "paymentforoptionexercise": 28000000,
    "contingentmilestonepaymentsreceivable": 300000000,
    "reimbursementofresearchanddevelopmentexpense": 8000000,
    "milestonepayments": 1000000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 6000000,
    "clinicalregulatorymilestonepayments": 50000000,
    "commercializationmilestonepayments": 375000000,
    "additionalclinicalregulatoryandcommercializationmilestonepayments": 14000000,
    "concentrationriskpercentage1": 0.96,
    "contractwithcustomerliability": 398000000,
    "deferredrevenue": 165000000,
    "contractwithcustomerinitialtransactionprice": 890000000,
    "domvanalimaboptionpaymentuponachievementofcertaindevelopmentmilestones": 275000000,
    "deferredrevenuerelatedtodomvanalimaboption": 37000000,
    "deferredrevenuerevenuerecognized1": 108000000,
    "deferredrevenuerelatedtodevelopmentandcommercializationservices": 10000000,
    "currentandfutureprogramsexclusiveaccessperiod": "P10Y",
    "optioncontinuationpaymentreceivableuponsixthanniversaryofagreement": 100000000,
    "deferredrevenuerelatedtoaccessrightsandoption": 92000000,
    "performanceobligationperiod": "P4Y",
    "contractualobligationremainingamountnotobligatedtopay": 300000000,
    "allocationtoperformanceobligations": 18000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -301000000,
    "currentfederaltaxexpensebenefit": 4000000,
    "currentstateandlocaltaxexpensebenefit": 2000000,
    "currentfederalstateandlocaltaxexpensebenefit": 6000000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.007,
    "effectiveincometaxratereconciliationequityinearningslossesofunconsolidatedsubsidiary": 0.004,
    "effectiveincometaxratereconciliationnondeductibleexpensebenefitresearchanddevelopment": 0.052,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.263,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.021,
    "effectiveincometaxratereconciliationnondeductibleexpensesandother": 0.005,
    "effectiveincometaxratecontinuingoperations": -0.02,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 1000000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 26000000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 21000000,
    "deferredtaxassetsdepreciationandamortization": 3000000,
    "deferredtaxassetsdeferredincome": 66000000,
    "deferredtaxassetsleasingarrangements": 26000000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 109000000,
    "deferredtaxassetsother": 1000000,
    "deferredtaxassetsgross": 253000000,
    "deferredtaxliabilitiesrightofuseassets": 20000000,
    "deferredincometaxliabilities": 20000000,
    "deferredtaxassetsvaluationallowance": 233000000,
    "valuationallowancedeferredtaxassetchangeinamount": 83000000,
    "taxcreditcarryforwardamount": 24000000,
    "operatinglosscarryforwards": 21000000,
    "unrecognizedtaxbenefits": 13000000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 2000000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 3000000,
    "weightedaveragenumberofsharesissuedbasic": 74000000,
    "earningspersharebasic": -4.15,
    "earningspersharediluted": -4.15,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 13500000,
    "allocatedsharebasedcompensationexpense": 35000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 73000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 35000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 13000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 3000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 25.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 21.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 28.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 25.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 13500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2900000,
    "stockissuedduringperiodsharesstockoptionsexercised": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 1100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 13500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 9000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 21.31,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 21.21,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 10.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 29.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 21.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 19.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y4M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 39000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 39000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 38000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.036,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.046,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.777,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.791,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 14.81,
    "definedcontributionplancostrecognized": 3000000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 85000000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 1000000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000000,
    "availableforsalesecuritiesdebtsecurities": 85000000,
    "cashandcashequivalentsfairvaluedisclosure": 127000000,
    "cashcashequivalentsandavailableforsaleinvestments": 866000000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 105,
    "restrictedcashnoncurrent": 3000000,
    "restrictedcashnoncurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "propertyplantandequipmentgross": 54000000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 31000000,
    "prepaidexpensesandothercurrentassets": 30000000,
    "interestreceivablecurrent": 4000000,
    "accruedresearchanddevelopmentexpensescurrent": 36000000,
    "employeerelatedliabilitiescurrent": 26000000,
    "operatingleaseliabilitycurrent": 11000000,
    "othersundryliabilitiescurrent": 3000000,
    "areaofland": 151000,
    "numberofleaseoptions": 2,
    "operatingleaseoptiontoextendleaseterm": "P8Y",
    "subleaseincome": 1000000,
    "operatingleaseweightedaverageremainingleaseterm1": "P8Y",
    "operatingleaseweightedaveragediscountratepercent": 0.052,
    "operatingleasecost": 18000000,
    "securitydeposit": 3000000,
    "operatingleaserightofuseasset": 92000000,
    "operatingleaseliabilitynoncurrent": 110000000,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent",
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent",
    "cashpaidforamountsincludedinmeasurementofleaseliabilities": 15000000,
    "cashreceivedfromtenantimprovementallowances": 9000000,
    "recognitionoftenantimprovementallowancereceivable": 4000000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 17000000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 17000000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 17000000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 18000000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 19000000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 61000000,
    "lesseeoperatingleaseliabilitypaymentsdue": 149000000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 28000000,
    "operatingleaseliability": 121000000,
    "saleofstockauthorizedconsiderationontransaction": 200000000,
    "saleofstocknumberofsharesissuedintransaction": 200000,
    "saleofstockconsiderationreceivedontransaction": 5000000,
    "preferredstocksharesauthorized": 10000000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "assetsfairvaluedisclosure": 85000000,
    "liabilitiesfairvaluedisclosure": 19000000,
    "liabilityforsaleoffutureroyalties": 19000000,
    "increaseinliabilityforsaleoffutureroyaltiesinterestaccretion": 2000000,
    "lineofcredit": 3000000,
    "purchasecommitmentscancellationperiod": "P30D"
  },
  {
    "date": "2022-12-30",
    "symbol": "RCUS",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RCUS",
    "entityregistrantname": "Arcus Biosciences, Inc.",
    "entitycentralindexkey": 1724521,
    "currentfiscalyearenddate": "December 31",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes ",
    "entityfilercategory": "Large accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "entityfilenumber": "001-38419",
    "entitytaxidentificationnumber": "47-3898435",
    "entityaddressaddressline1": "3928 Point Eden Way",
    "entityaddresscityortown": "Hayward",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94545,
    "cityareacode": 510,
    "localphonenumber": "694-6200",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "securityexchangename": "The New York Stock Exchange",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young, LLP",
    "auditorlocation": "San Mateo, California",
    "revenuefromcontractwithcustomerexcludingassessedtax": 33000000,
    "researchanddevelopmentexpense": 288000000,
    "generalandadministrativeexpense": 104000000,
    "operatingexpenses": 392000000,
    "operatingincomeloss": -280000000,
    "interestandotherincomeexpensenonoperatingnet": 16000000,
    "effectiveinterestonliabilityforsaleoffutureroyalties": 2000000,
    "nonoperatingincomeexpense": 14000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -266000000,
    "incometaxexpensebenefit": 1000000,
    "netincomeloss": -267000000,
    "incomelossfromcontinuingoperationsperbasicshare": -3.71,
    "incomelossfromcontinuingoperationsperdilutedshare": -3.71,
    "weightedaveragenumberofsharesoutstandingbasic": 72000000,
    "weightedaveragenumberofdilutedsharesoutstanding": 72000000,
    "revenuefromrelatedparties": 33000000,
    "relatedpartytransactionreimbursementfromrelatedpartyforsharedcosts": 1000000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -6000000,
    "comprehensiveincomenetoftax": -273000000,
    "cashandcashequivalentsatcarryingvalue": 206000000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 803000000,
    "contractwithcustomerassetnetcurrent": 39000000,
    "prepaidexpenseandotherassetscurrent": 19000000,
    "assetscurrent": 1067000000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 129000000,
    "propertyplantandequipmentnet": 35000000,
    "otherassetsnoncurrent": 114000000,
    "assets": 1345000000,
    "accountspayablecurrent": 20000000,
    "contractwithcustomerliabilitycurrent": 97000000,
    "otherliabilitiescurrent": 76000000,
    "liabilitiescurrent": 193000000,
    "contractwithcustomerliabilitynoncurrent": 355000000,
    "otherliabilitiesnoncurrent": 5000000,
    "commonstockvalue": 1206000000,
    "retainedearningsaccumulateddeficit": -542000000,
    "accumulatedothercomprehensiveincomelossnetoftax": -7000000,
    "stockholdersequity": -7000000,
    "liabilitiesandstockholdersequity": 1345000000,
    "accountsreceivablerelatedpartiescurrent": 39000000,
    "relatedpartiescontractassetsnoncurrent": 2000000,
    "deferredrevenuerelatedpartiesclassifiedcurrent": 97000000,
    "deferredrevenuerelatedpartiesnoncurrent": 355000000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 72900000,
    "commonstocksharesoutstanding": 72900000,
    "stockissuedduringperiodvaluenewissues": 23000000,
    "stockissuedduringperiodsharesnewissues": 2100000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 65000000,
    "othercomprehensiveincomelossnetoftax": -6000000,
    "profitloss": -267000000,
    "sharebasedcompensation": 65000000,
    "depreciationandamortization": 6000000,
    "operatingleaserightofuseassetamortizationexpense": 8000000,
    "otheroperatingactivitiescashflowstatement": 3000000,
    "increasedecreaseincontractwithcustomerasset": -704000000,
    "increasedecreaseinothernoncurrentassets": -2000000,
    "increasedecreaseinaccountspayable": 8000000,
    "increasedecreaseincontractwithcustomerliability": -112000000,
    "increasedecreaseinothernoncurrentliabilities": 21000000,
    "netcashprovidedbyusedinoperatingactivities": 438000000,
    "paymentstoacquiremarketablesecurities": 1241000000,
    "proceedsfrommaturityofmarketablesecurities": 694000000,
    "proceedsfromsaleofmarketablesecurities": 143000000,
    "paymentstoacquirepropertyplantandequipment": 6000000,
    "paymentstoacquireinprocessresearchanddevelopment": 6000000,
    "collaborationreimbursementsofinprocessresearchanddevelopmentfromrelatedparty": 3000000,
    "netcashprovidedbyusedininvestingactivities": -413000000,
    "proceedsfromsaleoffutureroyalties": 10000000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 23000000,
    "netcashprovidedbyusedinfinancingactivities": 33000000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 58000000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 209000000,
    "incometaxespaid": 3000000,
    "capitalexpendituresincurredbutnotyetpaid": 3000000,
    "receivablefromrelatedparty": -704000000,
    "otherassetsfromrelatedparty": 2000000,
    "deferredrevenuefromrelatedparty": -107000000,
    "numberofreportablesegments": 1,
    "numberofoperatingsegments": 1,
    "investmentsandcash": 1140000000,
    "propertyplantandequipmentusefullife": 5,
    "percentageofpremiumpurchasepriceofcommonstock": 0.2,
    "trailingdaysaverageclosingprice": "five-day",
    "shareprice": 30.37,
    "percentageofoutstandingcommonstockowned": 0.189,
    "upfrontcashpayment": 725000000,
    "optionpaymentuponachievementofcertaindevelopmentmilestones": 200000000,
    "optioncontinuationpaymentdueuponsecondanniversaryofagreement": 100000000,
    "numberofresearchprograms": 2,
    "optionpaymentuponcompletionofcertainindenablingactivities": 60000000,
    "righttopurchaseadditionaloutstandingvotingcommonstockpercentage": 0.35000000000000003,
    "contractwithcustomerliabilityrevenuerecognized": 107000000,
    "contractwithcustomerassetnet": 4000000,
    "contractwithcustomerassetnetnoncurrent": 2000000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 4000000,
    "rangeofroyaltiesreceivableonnetsales": "high single-digits to mid-teens",
    "royaltiespayabledescription": "Royalties will be payable by product and country commencing on the first commercial sale and ending upon the later of: (a) 10 years; and (b) expiration of the last-to-expire valid claim of our patents covering the manufacture, use or sale.",
    "additionalclinicalregulatoryandcommercializationmilestonepayments": 88000000,
    "milestonepayments": 2000000,
    "milestoneexpense": 5000000,
    "concentrationriskpercentage1": 0.96,
    "deferredrevenue": 87000000,
    "contractwithcustomerinitialtransactionprice": 890000000,
    "deferredrevenuerelatedtodomvanalimaboption": 37000000,
    "deferredrevenuerevenuerecognized1": 112000000,
    "earningspersharediluted": -3.71,
    "deferredrevenuerelatedtoetrumadenantoption": 127000000,
    "deferredrevenuerelatedtodevelopmentandcommercializationservices": 10000000,
    "deferredrevenuerelatedtoaccessrightsandoption": 92000000,
    "feeincurredwiththirdpartyuponreceiptofoptionexercisepayments": 4000000,
    "remainingcapitalizedfeesatclosing": 4000000,
    "feesallocatedamongperformanceobligations": 8000000,
    "capitalizedcontractcostamortization": 1000000,
    "capitalizedcontractcostnetcurrent": 1000000,
    "capitalizedcontractcostnetnoncurrent": 3000000,
    "valuationallowancedeferredtaxassetchangeinamount": 67000000,
    "taxcutsandjobsactcapitalizedresearchanddevelopmentcostamortizationperiod": "fifteen-year",
    "operatinglosscarryforwards": 19000000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "operatinglosscarryforwardswithnoexpirationdate": 109000000,
    "taxcreditcarryforwardamount": 3000000,
    "taxcreditcarryforwardexpirationyear": 2039,
    "opentaxyear": 2022,
    "unrecognizedtaxbenefits": 8000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -267000000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 1000000,
    "currentstateandlocaltaxexpensebenefit": 1000000,
    "currentfederalstateandlocaltaxexpensebenefit": 1000000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.001,
    "effectiveincometaxratereconciliationequityinearningslossesofunconsolidatedsubsidiary": 0.009000000000000001,
    "effectiveincometaxratereconciliationnondeductibleexpensebenefitresearchanddevelopment": 0.031000000000000003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.245,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.001,
    "effectiveincometaxratereconciliationnondeductibleexpensesandother": -0.006,
    "effectiveincometaxratecontinuingoperations": -0.001,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 24000000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 22000000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 16000000,
    "deferredtaxassetsdepreciationandamortization": 6000000,
    "deferredtaxassetsdeferredincome": 19000000,
    "deferredtaxassetsleasingarrangements": 25000000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 53000000,
    "deferredtaxassetsother": 7000000,
    "deferredtaxassetsgross": 172000000,
    "deferredtaxliabilitiesrightofuseassets": 22000000,
    "deferredincometaxliabilities": 22000000,
    "deferredtaxassetsvaluationallowance": 150000000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 3000000,
    "weightedaveragenumberofsharesissuedbasic": 72000000,
    "earningspersharebasic": -3.71,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 13500000,
    "allocatedsharebasedcompensationexpense": 65000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 90000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 37000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 26000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 48000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 15000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": " opted to use the “simplified method” for estimating the expected term of options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally 10 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 31.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 30.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 32.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 30.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 12000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2300000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 12000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 6700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 21.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 30.37,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 13.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 25.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 21.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 18.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 7.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 50000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 50000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 42000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.047,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.6890000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8250000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 20.75,
    "definedcontributionplancostrecognized": 2000000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 1145000000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 7000000,
    "availableforsalesecuritiesdebtsecurities": 1138000000,
    "cashandcashequivalentsfairvaluedisclosure": 206000000,
    "cashcashequivalentsandavailableforsaleinvestments": 1138000000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionnumberofpositions": 219,
    "restrictedcashnoncurrent": 3000000,
    "restrictedcashnoncurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent",
    "propertyplantandequipmentgross": 58000000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 23000000,
    "prepaidexpensesandothercurrentassets": 15000000,
    "interestreceivablecurrent": 4000000,
    "accruedresearchanddevelopmentexpensescurrent": 45000000,
    "employeerelatedliabilitiescurrent": 25000000,
    "othersundryliabilitiescurrent": 6000000,
    "areaofland": 109000,
    "operatingleaseexpirationyear": 2031,
    "lesseeoperatingleaseexistenceofoptiontoextend": "extend",
    "lesseeoperatingleaseoptiontoextend": "Both leases: are non-cancelable; extend through 2031; have two options, at our sole discretion, to extend the lease terms for a period of eight years each; and require monthly lease payments that are subject to annual increases throughout the lease term.",
    "operatingleaseoptiontoextendleaseterm": "eight years",
    "operatingleaseweightedaverageremainingleaseterm1": 9,
    "operatingleaseweightedaveragediscountratepercent": 0.052000000000000005,
    "operatingleasecost": 18000000,
    "lesseeoperatingleasetenantimprovementallowancereceivable": 6000000,
    "lesseeoperatingleasetenantimprovementallowancereceivableexpectedperiod": "one year",
    "securitydeposit": 3000000,
    "operatingleaserightofuseasset": 100000000,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent",
    "operatingleaseliabilitycurrent": 3000000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent",
    "operatingleaseliabilitynoncurrent": 117000000,
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent",
    "cashpaidforamountsincludedinmeasurementofleaseliabilities": 11000000,
    "cashreceivedfromtenantimprovementallowances": 8000000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 3000000,
    "recognitionoftenantimprovementallowancereceivable": 6000000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 15000000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 16000000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 16000000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 17000000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 18000000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 77000000,
    "lesseeoperatingleaseliabilitypaymentsdue": 159000000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 33000000,
    "operatingleaseliability": 126000000,
    "imputedeffectiverateofinterestonunamortizedportionofliability": 0.20600000000000002,
    "assetsfairvaluedisclosure": 1138000000,
    "liabilitiesfairvaluedisclosure": 17000000,
    "nonrefundablepaymentsreceived": 15000000,
    "liabilityforsaleoffutureroyalties": 17000000,
    "increaseinliabilityforsaleoffutureroyaltiescashreceived": 10000000,
    "increaseinliabilityforsaleoffutureroyaltiesinterestaccretion": 2000000,
    "purchasecommitmentscancellationperiod": 30,
    "lineofcredit": 3000000
  },
  {
    "date": "2021-12-30",
    "symbol": "RCUS",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RCUS",
    "entityregistrantname": "Arcus Biosciences, Inc.",
    "entitycentralindexkey": 1724521,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38419",
    "entitytaxidentificationnumber": "47-3898435",
    "entityaddressaddressline1": "3928 Point Eden Way",
    "entityaddresscityortown": "Hayward",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94545,
    "cityareacode": 510,
    "localphonenumber": "694-6200",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "securityexchangename": "NYSE",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young, LLP",
    "auditorlocation": "Redwood City, California",
    "cashandcashequivalentsatcarryingvalue": 147914000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 351394000,
    "contractwithcustomerassetnetcurrent": 744595000,
    "interestreceivablecurrent": 2227000,
    "prepaidexpenseandotherassetscurrent": 15620000,
    "assetscurrent": 1261750000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 181990000,
    "propertyplantandequipmentnet": 32455000,
    "operatingleaserightofuseasset": 104968000,
    "restrictedcashnoncurrent": 3005000,
    "otherassetsnoncurrent": 7730000,
    "assets": 1591898000,
    "accountspayablecurrent": 10261000,
    "accruedresearchanddevelopmentexpensescurrent": 29587000,
    "accruedliabilitiescurrent": 24181000,
    "contractwithcustomerliabilitycurrent": 102003000,
    "otherliabilitiescurrent": 52000,
    "liabilitiescurrent": 166084000,
    "contractwithcustomerliabilitynoncurrent": 462217000,
    "operatingleaseliabilitynoncurrent": 116887000,
    "otherliabilitiesnoncurrent": 5260000,
    "liabilities": 750448000,
    "commonstockvalue": 7000,
    "additionalpaidincapital": 1118058000,
    "retainedearningsaccumulateddeficit": -275354000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1261000,
    "stockholdersequity": 841450000,
    "liabilitiesandstockholdersequity": 1591898000,
    "accountsreceivablerelatedpartiescurrent": 744535000,
    "deferredrevenuerelatedpartiesclassifiedcurrent": 96981000,
    "deferredrevenuerelatedpartiesnoncurrent": 462217000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 70781736,
    "commonstocksharesoutstanding": 70781736,
    "commonstocksharesoutstandingincludessharesissuedbutsubjecttovesting": 9946,
    "revenuefromcontractwithcustomerexcludingassessedtax": 343838000,
    "researchanddevelopmentexpense": 256348000,
    "generalandadministrativeexpense": 72286000,
    "operatingexpenses": 328634000,
    "operatingincomeloss": 54248000,
    "interestandotherincomeexpensenonoperatingnet": 657000,
    "effectiveinterestonliabilityforsaleoffutureroyalties": 260000,
    "nonoperatingincomeexpense": 397000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 54645000,
    "incometaxexpensebenefit": 1815000,
    "netincomeloss": 52830000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -1305000,
    "comprehensiveincomenetoftax": 51525000,
    "incomelossfromcontinuingoperationsperbasicshare": 0.76,
    "weightedaveragenumberofsharesoutstandingbasic": 69345490,
    "incomelossfromcontinuingoperationsperdilutedshare": 0.71,
    "weightedaveragenumberofdilutedsharesoutstanding": 73966267,
    "revenuefromrelatedparties": 328838000,
    "relatedpartytransactionreimbursementfromrelatedpartyforsharedcosts": 24891000,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 5650000,
    "stockissuedduringperiodsharesstockoptionsexercised": 680755,
    "stockissuedduringperiodvaluestockoptionsexercisedandvestingofrestrictedstock": 9089000,
    "stockissuedduringperiodsharesstockoptionsexercisedandvestingofrestrictedstock": 1045423,
    "stockissuedduringperiodvaluevestingofearlyexercisedstockoption": 686000,
    "stockissuedduringperiodsharesvestingofearlyexercisedstockoption": 153877,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 3022000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 230589,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 54528000,
    "othercomprehensiveincomelossnetoftax": -1305000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 55000,
    "profitloss": 52830000,
    "sharebasedcompensation": 54528000,
    "depreciationandamortization": 3843000,
    "operatingleaserightofuseassetamortizationexpense": 3214000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -4772000,
    "increasedecreaseincontractwithcustomerasset": 17046000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 5944000,
    "increasedecreaseinothernoncurrentassets": -3322000,
    "increasedecreaseinaccountspayable": -4773000,
    "increasedecreaseinaccruedresearchanddevelopmentexpenses": 8355000,
    "increasedecreaseinotheraccruedliabilities": 10138000,
    "increasedecreaseincontractwithcustomerliability": -367884000,
    "increasedecreaseinoperatingleaseliabilities": -1288000,
    "increasedecreaseinothernoncurrentliabilities": -498000,
    "netcashprovidedbyusedinoperatingactivities": -256171000,
    "paymentstoacquireinvestments": 718865000,
    "proceedsfromsalematurityandcollectionsofinvestments": 690074000,
    "proceedsfromsaleofshorttermandlongterminvestments": 51001000,
    "paymentstoacquirepropertyplantandequipment": 26078000,
    "netcashprovidedbyusedininvestingactivities": -3868000,
    "proceedsfromissuanceofcommonstock": 220235000,
    "proceedsfromsaleoffutureroyalties": 5000000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 12111000,
    "repurchaseofunvestedsharesofstock": 6000,
    "netcashprovidedbyusedinfinancingactivities": 237340000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -22699000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 150919000,
    "capitalexpendituresincurredbutnotyetpaid": 996000,
    "unpaidportionofotherassetsincludedinaccruedresearchanddevelopment": 1425000,
    "vestingofearlyexercisedstockoptionsandrestrictedstock": 686000,
    "receivablefromrelatedparty": -17092000,
    "deferredrevenuefromrelatedparty": -360884000,
    "proceedsfromissuanceofcommonstockfromrelatedparty": 220235000,
    "numberofinvestigationalproduct": 6,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P1Y",
    "operatingleaseexpirationyear": 2031,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-01-01",
    "operatingleaseliability": 113600000,
    "operatingleaseliabilitycurrent": 5100000,
    "areaofland": 136293,
    "assetsfairvaluedisclosure": 147914000,
    "cashandcashequivalentsfairvaluedisclosure": 147914000,
    "cashcashequivalentsandavailableforsaleinvestments": 681298000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 147914000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 1000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 304000,
    "availableforsalesecuritiesdebtsecurities": 147914000,
    "propertyplantandequipmentgross": 13856000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 17728000,
    "employeerelatedliabilitiescurrent": 16648000,
    "accruedprofessionalfeescurrent": 4938000,
    "accruedincometaxescurrent": 1815000,
    "otheraccruedliabilities": 780000,
    "otheraccruedliabilitiescurrent": 24181000,
    "operatingleasecommencementyear": 2022,
    "lesseeoperatingleasetermofcontract": "P3M",
    "lesseeoperatingleaseoptiontoextend": "the lease amendment and replaced by two options to extend the lease term for the entire 150,753 square feet then under lease in the Hayward premises for a period of eight years each.",
    "lesseeoperatingleaseexistenceofoptiontoextend": "true",
    "operatingleaseoptiontoextendleaseterm": "P8Y",
    "operatingleaseweightedaverageremainingleaseterm1": "P10Y",
    "operatingleaseweightedaveragediscountratepercent": 0.051,
    "operatingleasecost": 7100000,
    "shorttermleasecost": 300000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent",
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 36562000,
    "lesseeoperatingleaseleasenotyetcommenceddescription": "Total undiscounted future minimum lease payments do not include approximately $5.3 million related to the Company’s lease of additional space lease in Hayward that has not yet commenced.",
    "securitydeposit": 3000000,
    "operatingleaseexpirationdate": "2031-12-31",
    "lesseeoperatingleaseleasescommencemonthandyear": "2021-11",
    "lesseeoperatingleasetenantimprovementallowancereceivable": 8400000,
    "lesseeoperatingleasetenantimprovementallowancereceivableexpectedperiod": "P1Y",
    "cashpaidforamountsincludedinmeasurementofleaseliabilities": 4890000,
    "cashreceivedfromtenantimprovementallowances": 2967000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 95401000,
    "recognitionoftenantimprovementallowancereceivableincludedinothercurrentassets": 10598000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 11198000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 14281000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 14759000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 15255000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 15769000,
    "lesseeoperatingleaseliabilitypaymentsduethereafter": 87236000,
    "lesseeoperatingleaseliabilitypaymentsdue": 158498000,
    "tenantimprovementallowanceexpectedtobereceivedinlessthanoneyearnetofcurrentportionofleaseliability": 3332000,
    "cashreceivedfromcounterparty": 15000000,
    "researchanddevelopmentarrangementliabilityformilestonepaymentsandroyalties": 5300000,
    "imputedeffectiverateofinterestonunamortizedportionofliability": 0.206,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 5260000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitycashreceived": 5000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityinterestaccretion": 260000,
    "revenues": 343838000,
    "deferredrevenuerevenuerecognized1": 202082000,
    "upfrontcashpayment": 725000000,
    "upfrontandmilestonepayments": 14600000,
    "optioncontinuationpaymentdueuponsecondanniversaryofagreement": 100000000,
    "feeincurredwiththirdpartyuponreceiptofoptionexercisepayments": 4500000,
    "contractwithcustomerinitialtransactionprice": 890100000,
    "optionpaymentuponachievementofcertaindevelopmentmilestones": 200000000,
    "deferredrevenuerelatedtodevelopmentandcommercializationservices": 9700000,
    "deferredrevenuerelatedtoresearchanddevelopmentpipeline": 120200000,
    "capitalizedcosts": 3800000,
    "contractwithcustomerassetnet": 4900000,
    "contractwithcustomerassetnetnoncurrent": 4000000,
    "rangeofroyaltiesreceivableonnetsales": "high single-digits to mid-teens",
    "nonrefundableandnoncreditableupfrontcashpayments": 35000000,
    "estimatedperformanceperiodofagreement": "P5Y",
    "clinicalandregulatorymilestonesachievedunderlicenseagreement": 16500000,
    "deferredrevenue": 165100000,
    "deferredrevenuecurrent": 5000000,
    "milestonepayments": 10000000,
    "rangeoftieredroyaltypaymentsonnetsales": "high single-digits to low teens",
    "clinicalregulatoryandcommercializationremainingmilestonepayments": 93000000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 1000000,
    "increasedecreaseinresearchanddevelopmentexpense": 24900000,
    "remainingcapitalizedfeesatclosing": 3800000,
    "feesallocatedamongperformanceobligations": 8300000,
    "milestoneexpense": 5000000,
    "capitalstocksharesauthorized": 410000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 9946,
    "deferredcompensationsharebasedarrangementsliabilitycurrentandnoncurrent": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P48M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 5000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2226271,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesissuedinperiod": 2288000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 17400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 52400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 22.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 34.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiodinterval": "annually or quarterly",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3758769,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 12100000,
    "commonstockcapitalsharesreservedforfutureissuance": 1610979,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 37250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 1291,
    "stockbasedcompensationexpense": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 102900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": "The Company has opted to use the “simplified method” for estimating the expected term of options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally 10 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 12019912,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 950799,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 12019912,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5158246,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 19.46,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 33.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 13.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 19.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 19.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 14.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y1M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 253620000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 253620000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 133742000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 932362,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 382183,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 212741,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 32.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 31.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 26.06,
    "allocatedsharebasedcompensationexpense": 28302000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.014,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.753,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.776,
    "weightedaveragenumberofsharesissuedbasic": 70328234,
    "weightedaveragenumberofsharescommonstocksubjecttorepurchaseorcancellation": 982744,
    "incrementalcommonsharesattributabletosharebasedpaymentarrangements": 4054142,
    "earningspersharebasic": 0.76,
    "earningspersharediluted": 0.71,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4512973,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 53898000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 747000,
    "currentfederaltaxexpensebenefit": 1252000,
    "currentstateandlocaltaxexpensebenefit": 563000,
    "currentfederalstateandlocaltaxexpensebenefit": 1815000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0081,
    "effectiveincometaxratereconciliationequityinearningslossesofunconsolidatedsubsidiary": -0.0407,
    "effectiveincometaxratereconciliationnondeductibleexpensebenefitresearchanddevelopment": -0.1191,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.0255,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.0075,
    "effectiveincometaxratereconciliationnondeductibleexpensesandother": 0.0079,
    "effectiveincometaxratecontinuingoperations": 0.0332,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 24183000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 13288000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 9857000,
    "deferredtaxassetsleaseliability": 6140000,
    "deferredtaxassetsdeferredincome": 23557000,
    "deferredtaxassetsleasingarrangements": 25389000,
    "deferredtaxassetsother": 3478000,
    "deferredtaxassetsgross": 105892000,
    "deferredtaxliabilitiesrightofuseassets": 22800000,
    "deferredincometaxliabilities": 22800000,
    "deferredtaxassetsvaluationallowance": 83092000,
    "valuationallowancedeferredtaxassetchangeinamount": -1100000,
    "operatinglosscarryforwards": 13000000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "operatinglosscarryforwardswithnoexpirationdate": 110500000,
    "taxcreditcarryforwardamount": 11700000,
    "taxcreditcarryforwardexpirationyear": 2035,
    "opentaxyear": 2015,
    "unrecognizedtaxbenefits": 5400000,
    "unrecognizedtaxbenefitsincreasesdecreasesresultingfrompriorperiodtaxpositions": -50000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 2325000,
    "purchasecommitmentscancellationperiod": "P30D",
    "percentageofoutstandingcommonstockowned": 0.195,
    "righttopurchaseadditionaloutstandingvotingcommonstockpercentage": 0.35,
    "contractwithcustomerliabilityrevenuerecognized": 360900000,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1,
    "definedcontributionplancostrecognized": 700000
  },
  {
    "date": "2020-12-30",
    "symbol": "RCUS",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RCUS",
    "entityregistrantname": "Arcus Biosciences, Inc.",
    "entitycentralindexkey": 1724521,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38419",
    "entitytaxidentificationnumber": "47-3898435",
    "entityaddressaddressline1": "3928 Point Eden Way",
    "entityaddresscityortown": "Hayward",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94545,
    "cityareacode": 510,
    "localphonenumber": "694-6200",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "securityexchangename": "The New York Stock Exchange",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "true",
    "cashandcashequivalentsatcarryingvalue": 173415000,
    "availableforsalesecuritiescurrent": 555231000,
    "contractwithcustomerassetnetcurrent": 900000,
    "interestreceivablecurrent": 649000,
    "prepaidexpenseandotherassetscurrent": 5471000,
    "assetscurrent": 735815000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 6440000,
    "propertyplantandequipmentnet": 10807000,
    "operatingleaserightofuseasset": 12781000,
    "restrictedcashnoncurrent": 203000,
    "otherassetsnoncurrent": 6246000,
    "assets": 772292000,
    "accountspayablecurrent": 15682000,
    "accruedresearchanddevelopmentexpensescurrent": 18307000,
    "accruedliabilitiescurrent": 9543000,
    "contractwithcustomerliabilitycurrent": 7000000,
    "otherliabilitiescurrent": 3566000,
    "liabilitiescurrent": 121669000,
    "contractwithcustomerliabilitynoncurrent": 117800000,
    "operatingleaseliabilitynoncurrent": 15243000,
    "otherliabilitiesnoncurrent": 10246000,
    "liabilities": 269988000,
    "commonstockvalue": 6000,
    "additionalpaidincapital": 830438000,
    "retainedearningsaccumulateddeficit": -328184000,
    "accumulatedothercomprehensiveincomelossnetoftax": 44000,
    "stockholdersequity": 44000,
    "liabilitiesandstockholdersequity": 772292000,
    "accountsreceivablerelatedpartiescurrent": 943000,
    "deferredrevenuerelatedpartiesclassifiedcurrent": 67571000,
    "deferredrevenuerelatedpartiesnoncurrent": 117808000,
    "relatedpartiescontractliabilitiesnoncurrent": 9703000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 7000000,
    "researchanddevelopmentexpense": 500000,
    "generalandadministrativeexpense": 42404000,
    "operatingexpenses": 201752000,
    "operatingincomeloss": -124235000,
    "interestandotherincomeexpensenonoperatingnet": 1377000,
    "gainlossonsaleofequityinvestments": 2000000,
    "incomelossfromequitymethodinvestments": 600000,
    "nonoperatingincomeexpense": 1377000,
    "netincomeloss": -122858000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -20000,
    "comprehensiveincomenetoftax": -122878000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -2.24,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "revenuefromrelatedparties": 15421000,
    "relatedpartytransactionreimbursementfromrelatedpartyforsharedcosts": 3400000,
    "stockissuedduringperiodvaluenewissues": 107468000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodsharesstockoptionsexercised": 392523,
    "stockissuedduringperiodvaluestockoptionsexercisedandvestingofrestrictedstock": 3366000,
    "stockissuedduringperiodsharesstockoptionsexercisedandvestingofrestrictedstock": 405752,
    "stockissuedduringperiodvaluevestingofearlyexercisedstockoptionsandrestrictedstock": 848000,
    "stockissuedduringperiodsharesvestingofearlyexercisedstockoptionsandrestrictedstock": 258824,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1587000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 202101,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 21825000,
    "othercomprehensiveincomelossnetoftax": -20000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 1931000,
    "costsandexpensesrelatedparty": 3762000,
    "profitloss": -122858000,
    "sharebasedcompensation": 21825000,
    "depreciationandamortization": 3149000,
    "operatingleaserightofuseassetamortizationexpense": 1042000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 46000,
    "increasedecreaseincontractwithcustomerasset": 917000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 838000,
    "increasedecreaseinothernoncurrentassets": 5374000,
    "increasedecreaseinaccountspayable": 9272000,
    "increasedecreaseinaccruedresearchanddevelopmentexpenses": 13735000,
    "increasedecreaseinotheraccruedliabilities": 4593000,
    "increasedecreaseincontractwithcustomerliability": 178379000,
    "increasedecreaseinoperatingleaseliabilities": -993000,
    "increasedecreaseinothernoncurrentliabilities": 10201000,
    "netcashprovidedbyusedinoperatingactivities": 111170000,
    "paymentstoacquireinvestments": 739658000,
    "proceedsfromsalematurityandcollectionsofinvestments": 307343000,
    "proceedsfromsaleofshortterminvestments": 1003000,
    "paymentstoacquirepropertyplantandequipment": 3055000,
    "netcashprovidedbyusedininvestingactivities": -434367000,
    "proceedsfromissuanceofcommonstock": 433776000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 4953000,
    "repurchaseofunvestedsharesofstock": 54000,
    "netcashprovidedbyusedinfinancingactivities": 438675000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 115478000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 173618000,
    "cashpaidforamountsincludedinmeasurementofleaseliabilities": 2105000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 8019000,
    "unpaidportionoffinancingcostsincludedinaccountpayable": 61000,
    "capitalexpendituresincurredbutnotyetpaid": 1583000,
    "vestingofearlyexercisedstockoptionsandrestrictedstock": 848000,
    "receivablefromrelatedparty": 943000,
    "deferredrevenuefromrelatedparty": 185379000,
    "otherlongtermliabilitiesfromrelatedparty": 9703000,
    "numberofinvestigationalproduct": 4,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "five years",
    "operatingleaseexpirationyear": 2029,
    "operatingleasecommencementyear": 2021,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "changeinaccountingprincipleaccountingstandardsupdateearlyadoption": "true",
    "operatingleaseliability": 18100000,
    "operatingleaseliabilitycurrent": 2900000,
    "assetsfairvaluedisclosure": 588618000,
    "cashandcashequivalentsfairvaluedisclosure": 173415000,
    "availableforsalesecuritiesnoncurrent": 6440000,
    "cashcashequivalentsandavailableforsaleinvestments": 735086000,
    "availableforsalesecuritiesamortizedcost": 735042000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 57000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 13000,
    "availableforsalesecurities": 735086000,
    "propertyplantandequipmentgross": 25095000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 14288000,
    "employeerelatedliabilitiescurrent": 8632000,
    "accruedprofessionalfeescurrent": 295000,
    "otheraccruedliabilities": 616000,
    "otheraccruedliabilitiescurrent": 9543000,
    "gainlossonequityinvestmentsnetofpriorperiodlosses": -1400000,
    "operatinglossfromequitymethodinvestments": 600000,
    "unrealizedgainlossonequitymethodinvestments": -1300000,
    "areaofland": 109237,
    "lesseeoperatingleasetermofcontract": "ten years",
    "operatingleasesfutureminimumpaymentsdue": 90300000,
    "lesseeoperatingleaseallowancefortenantimprovements": 12600000,
    "lesseeoperatingleasespacedeliveredmonthandyear": "August 2020",
    "lesseeoperatingleaseoptiontoincreaseallowancefortenantimprovements": 5500000,
    "operatingleaseweightedaverageremainingleaseterm1": 6.2,
    "operatingleaseweightedaveragediscountratepercent": 0.073,
    "operatingleasecost": 2700000,
    "shorttermleasecost": 200000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherCurrentLiabilitiesMember",
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 90300000,
    "lesseeoperatingleaseleasenotyetcommenceddescription": "Total undiscounted future minimum lease payments do not include approximately $90.3 million related to the Company’s Brisbane lease that has not yet commenced.",
    "lesseeoperatingleaseleasescommenceyear": 2021,
    "lesseeoperatingleaseleasenotyetcommencedtermofcontract1": 10,
    "subleaseincome": 100000,
    "lesseeoperatingleaseleasenotyetcommencedexistenceofoptiontoterminate": "false",
    "securitydeposit": 200000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4041000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3409000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 3522000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 3640000,
    "lesseeoperatingleaseliabilitypaymentsdueyearsix": 3340000,
    "lesseeoperatingleaseliabilitypaymentsduethereafter": 4311000,
    "lesseeoperatingleaseliabilitypaymentsdue": 22263000,
    "revenues": 77517000,
    "deferredrevenuerevenuerecognized1": 7000000,
    "upfrontcashpayment": 175000000,
    "unconstrainedconsiderationreceivable": 100000000,
    "fundsreceivedforstockpurchaseagreement": 200000000,
    "fairvalueofstockpurchased": 109400000,
    "premiumpaidonstockpurchaseagreement": 90600000,
    "deferredrevenuerelatedtoetrumadenantoption": 127000000,
    "etrumadenantoptioninitialtermofagreement": "P4Y",
    "deferredrevenuerelatedtodomvanalimaboption": 36700000,
    "domvanalimaboptionrecognizedterm": "one year",
    "deferredrevenuerelatedtoresearchanddevelopmentpipeline": 121700000,
    "futuredevelopmentandpromotioncostscontractliability": 9700000,
    "adjustmentforamortization": 200000,
    "contractwithcustomerassetnet": 4200000,
    "contractwithcustomerassetnetnoncurrent": 3200000,
    "rangeofroyaltiesreceivableonnetsales": "high single-digits to mid-teens",
    "nonrefundableandnoncreditableupfrontcashpayments": 35000000,
    "estimatedperformanceperiodofagreement": "five years",
    "contractwithcustomerliabilityrevenuerecognized": 70500000,
    "milestonepayments": 3,
    "sublicensefeesincurred": 10100000,
    "rangeoftieredroyaltypaymentsonnetsales": "high single-digits to low teens",
    "clinicalregulatoryandcommercializationremainingmilestonepayments": 98000000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 1700000,
    "reimbursementofresearchanddevelopmentexpenseexcludingacquiredinprocesscost": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "allocatedsharebasedcompensationexpense": 21825000,
    "paymentforaccessrightsrelatedtothecompanysresearch": 100000000,
    "premiumfromstockpurchaseagreement": 90600000,
    "allocationoftransactionprice": 365600000,
    "zimberelimablicense": 55096000,
    "etrumadenantoption": 126960000,
    "domvanalimaboption": 36728000,
    "accessrightsrelatedtocompanysresearchanddevelopmentpipeline": 137113000,
    "developmentandcommercializationservicesforzimberelimab": 9703000,
    "allocationtoperformanceobligations": 365600000,
    "capitalstocksharesauthorized": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 738650,
    "deferredcompensationsharebasedarrangementsliabilitycurrentandnoncurrent": 700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 784975,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 6800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 16800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiodinterval": "annually",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedinperiodtotalfairvalue": 21100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 100000,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 31986,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 21165,
    "stockbasedcompensationexpense": 700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 88900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": "The Company has opted to use the “simplified method” for estimating the expected term of options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally 10 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 237334,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 17.36,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 10.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 13.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.28,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y9M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y9M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y1M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 122232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 122232000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 44012000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 758950,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 6250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 14050,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 27.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 27.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 29.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.666,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.36,
    "weightedaveragenumberofsharesissuedbasic": "null",
    "weightedaveragenumberofsharescommonstocksubjecttorepurchaseorcancellation": "null",
    "earningspersharebasicanddiluted": -2.24,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationequityinearningslossesofunconsolidatedsubsidiary": 0.0415,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.031000000000000003,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2735,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.009000000000000001,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 54526000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 11209000,
    "deferredtaxassetsleaseliability": 9068000,
    "deferredtaxassetsdeferredincome": 2407000,
    "deferredtaxassetsleasingarrangements": 3831000,
    "deferredtaxassetsother": 5890000,
    "deferredtaxassetsgross": 86931000,
    "deferredtaxliabilitiesrightofuseassets": 2704000,
    "deferredincometaxliabilities": 2704000,
    "deferredtaxassetsvaluationallowance": 84227000,
    "valuationallowancedeferredtaxassetchangeinamount": 33800000,
    "operatinglosscarryforwards": 15900000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "operatinglosscarryforwardswithnoexpirationdate": 205900000,
    "taxcreditcarryforwardamount": 5100000,
    "taxcreditcarryforwardexpirationyear": 2035,
    "opentaxyear": 2019,
    "unrecognizedtaxbenefits": 3200000,
    "unrecognizedtaxbenefitsincreasesdecreasesresultingfrompriorperiodtaxpositions": -258000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1246000,
    "purchasecommitmentscancellationperiod": 30,
    "percentageofoutstandingcommonstockowned": 0.13,
    "righttopurchaseadditionaloutstandingvotingcommonstockpercentage": 0.35000000000000003,
    "contractwithcustomerliability": 185400000,
    "futuredevelopmentandcommercializationservicescontractliability": 9700000,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1
  },
  {
    "date": "2019-12-30",
    "symbol": "RCUS",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "RCUS",
    "entityregistrantname": "Arcus Biosciences, Inc.",
    "entitycentralindexkey": 1724521,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38419",
    "entitytaxidentificationnumber": "47-3898435",
    "entityaddressaddressline1": "3928 Point Eden Way",
    "entityaddresscityortown": "Hayward",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94545,
    "cityareacode": 510,
    "localphonenumber": "694-6200",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, Par Value $0.0001 Per Share",
    "securityexchangename": "NYSE",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 57937000,
    "availableforsalesecuritiescurrent": 130333000,
    "contractwithcustomerassetnetcurrent": 132000,
    "prepaidexpenseandotherassetscurrent": 4303000,
    "assetscurrent": 192705000,
    "propertyplantandequipmentnet": 9330000,
    "restrictedcashnoncurrent": 203000,
    "otherassetsnoncurrent": 872000,
    "assets": 203110000,
    "accountspayablecurrent": 4704000,
    "accruedliabilitiescurrent": 9522000,
    "deferredrevenuecurrent": 7000000,
    "otherliabilitiescurrent": 1480000,
    "liabilitiescurrent": 22706000,
    "deferredrevenuenoncurrent": 12000000,
    "deferredrentcreditnoncurrent": 3734000,
    "otherliabilitiesnoncurrent": 806000,
    "liabilities": 39268000,
    "commonstockvalue": 4000,
    "additionalpaidincapital": 369100000,
    "retainedearningsaccumulateddeficit": -2489000,
    "accumulatedothercomprehensiveincomelossnetoftax": 64000,
    "stockholdersequity": 64000,
    "liabilitiesandstockholdersequity": 203110000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 400000000,
    "commonstocksharesissued": 45925004,
    "commonstocksharesoutstanding": 44212195,
    "revenues": 15000000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseAndServiceMember",
    "researchanddevelopmentexpense": 78481000,
    "generalandadministrativeexpense": 25228000,
    "operatingexpenses": 103709000,
    "operatingincomeloss": -88709000,
    "interestandotherincomeexpensenonoperatingnet": 5201000,
    "incomelossfromequitymethodinvestments": -1200000,
    "nonoperatingincomeexpense": 3999000,
    "netincomeloss": 278000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 171000,
    "comprehensiveincomenetoftax": -84539000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -1.93,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 43825991,
    "cumulativeeffectonretainedearningsnetoftax1": 2212000,
    "stockissuedduringperiodvaluestockoptionsexercised": 188000,
    "stockissuedduringperiodsharesstockoptionsexercised": 41762,
    "stockissuedduringperiodvaluevestingofearlyexercisedstockoptionsandrestrictedstock": 1029000,
    "stockissuedduringperiodsharesvestingofearlyexercisedstockoptionsandrestrictedstock": 417883,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1029000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 148709,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8981000,
    "othercomprehensiveincomelossnetoftax": 171000,
    "profitloss": -84710000,
    "sharebasedcompensation": 8981000,
    "depreciationandamortization": 3578000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 2638000,
    "increasedecreaseincontractwithcustomerasset": 132000,
    "increasedecreaseinduefromrelatedpartiescurrent": -83000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1982000,
    "increasedecreaseinothernoncurrentassets": 588000,
    "increasedecreaseinaccountspayable": 1726000,
    "increasedecreaseinaccruedliabilities": 3499000,
    "increasedecreaseinothercurrentliabilities": 57000,
    "increasedecreaseindeferredrevenue": -2000000,
    "increasedecreaseindeferredrent": -538000,
    "netcashprovidedbyusedinoperatingactivities": -73462000,
    "paymentstoacquireinvestments": 247755000,
    "proceedsfromsalematurityandcollectionsofinvestments": 308892000,
    "paymentstoacquirepropertyplantandequipment": 1925000,
    "netcashprovidedbyusedininvestingactivities": 59212000,
    "proceedsfromissuanceofcommonstock": 1217000,
    "paymentsforrepurchaseofcommonstock": 94000,
    "netcashprovidedbyusedinfinancingactivities": 1123000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -13127000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 58140000,
    "capitalexpendituresincurredbutnotyetpaid": 12000,
    "vestingofearlyexercisedstockoptionsandrestrictedstock": 1029000,
    "stockholdersequityreversestocksplit": "the Company effected a reverse split of all shares of its common and preferred stock at a ratio of 1-for-3.96",
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "nonrefundableupfrontresearchanddevelopmentfeesterm": "P5Y",
    "nonrefundableandnoncreditableupfrontcashpaymentreceived": 35000000,
    "paymentreceivedforlicenseagreement": 5000000,
    "additionalpaymenttobereceivedforlicenseagreement": 5000000,
    "estimatedperformanceperiodofagreement": "P5Y",
    "contractwithcustomerliabilitycurrent": -917000,
    "contractwithcustomerliabilitynoncurrent": -1572000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 278000,
    "earningspersharebasicanddiluted": 0.01,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 58140000,
    "assetsfairvaluedisclosure": 142772000,
    "cashandcashequivalentsfairvaluedisclosure": 57937000,
    "cashcashequivalentsandavailableforsaleinvestments": 188270000,
    "availableforsalesecuritiesamortizedcost": 188206000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedgainbeforetax": 67000,
    "availableforsalesecuritiesaccumulatedgrossunrealizedlossbeforetax": 3000,
    "availableforsalesecurities": 188270000,
    "propertyplantandequipmentgross": 20551000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 11221000,
    "employeerelatedliabilitiescurrent": 4571000,
    "accruedresearchanddevelopmentexpensescurrent": 4572000,
    "accruedprofessionalfeescurrent": 183000,
    "otheraccruedliabilitiescurrent": 196000,
    "unrealizedgainlossonequitymethodinvestments": -800000,
    "rangeofroyaltiesreceivableonnetsales": "high single-digits to mid-teens",
    "nonrefundableandnoncreditableupfrontcashpayments": 35000000,
    "paymentforfirstoptionexercise": 8000000,
    "contractwithcustomerliabilityrevenuerecognized": 8000000,
    "deferredrevenuerevenuerecognized1": 7000000,
    "milestonepayments": 2500000,
    "sublicensefeespaid": 1200000,
    "rangeoftieredroyaltypaymentsonnetsales": "high single-digits to low teens",
    "clinicalregulatoryandcommercializationremainingmilestonepayments": 101000000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 1000000,
    "reimbursementofresearchanddevelopmentexpenseexcludingacquiredinprocesscost": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 4738004,
    "allocatedsharebasedcompensationexpense": 8981000,
    "capitalstocksharesauthorized": 410000000,
    "commonstockcapitalsharesreservedforfutureissuance": 933273,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 308596,
    "deferredcompensationsharebasedarrangementsliabilitycurrentandnoncurrent": 1700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P48M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2315099,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 23700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 7800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 372774,
    "stockbasedcompensationexpense": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": "The Company has opted to use the “simplified method” for estimating the expected term of options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally 10 years).",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4738004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3967746,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 646060,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1145303,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.66,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 10.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y9M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y9M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y11M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 8174000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 8174000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2851000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 289352,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 0.000396,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.023,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.648,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.771,
    "weightedaveragenumberofsharesoutstandingbasic": 45385489,
    "weightedaveragenumberofsharescommonstocksubjecttorepurchaseorcancellation": 1559498,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6450813,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0135,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.1965,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 30049000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 8077000,
    "deferredtaxassetdepreciation": 6052000,
    "deferredtaxassetsdeferredincome": 3277000,
    "deferredtaxassetsother": 2965000,
    "deferredtaxassetsgross": 50420000,
    "deferredtaxassetsvaluationallowance": 50420000,
    "valuationallowancedeferredtaxassetchangeinamount": 19700000,
    "operatinglosscarryforwards": 16900000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "operatinglosscarryforwardswithnoexpirationdate": 89700000,
    "taxcreditcarryforwardamount": 5000000,
    "taxcreditcarryforwardexpirationyear": 2035,
    "opentaxyear": 2018,
    "unrecognizedtaxbenefits": 2165000,
    "unrecognizedtaxbenefitsincreasesdecreasesresultingfrompriorperiodtaxpositions": -7000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1088000,
    "purchasecommitmentscancellationperiod": "P30D",
    "operatingleaseexpirationyear": 2025,
    "operatingleasesrentexpensenet": 1600000,
    "securitydeposit": 200000,
    "capitalleasesfutureminimumsubleaserentals": 100000,
    "operatingleasesfutureminimumpaymentsduecurrent": 2105000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 2195000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 2265000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 2339000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 2415000,
    "operatingleasesfutureminimumpaymentsdueinsixyearsandthereafter": 2072000,
    "operatingleasesfutureminimumpaymentsdue": 13391000,
    "definedcontributionplanmaximumannualcontributionsperemployeepercent": 1
  }
]